Related Experiment Videos
Upper age limit for the development of amblyopia
1Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City 52242, USA.
Insights
Children rarely develop amblyopia after age 6. The study found age at onset of an amblyopia-inducing condition is key, with no cases developing after 73 months.
Area of Science:
- Ophthalmology
- Pediatric Medicine
- Developmental Neuroscience
Background:
- Amblyopia, or "lazy eye," is a common cause of reduced vision in children.
- Early detection and intervention are crucial for effective amblyopia treatment.
- Understanding the age-related risks for amblyopia development is essential for clinical practice.
Purpose of the Study:
- To determine the upper age limit for amblyopia development in children.
- To identify the critical factors influencing amblyopia onset in pediatric patients.
Main Methods:
- Retrospective review of medical records for 64 patients (ages 1-11) with amblyopia-inducing conditions.
- Comparison of patient age at the onset of the condition between groups that developed amblyopia and those that did not.
- Statistical analysis to determine the significance of age and other factors.
Main Results:
- Amblyopia developed in 37 patients (group 1) and not in 27 (group 2).
- Mean age at onset was significantly lower in group 1 (41.0 months) versus group 2 (92.3 months).
- No amblyopia developed in any patient after 73 months of age; older children (≥6 years) had a low probability of developing amblyopia.
Conclusions:
- Patient age at the onset of an amblyopia-inducing condition is the primary determinant for developing amblyopia.
- The upper age limit for amblyopia development appears to be around 73 months (approximately 6 years).
- Children aged 6 years and older with normal visual systems have a low risk of developing amblyopia if an inducing condition arises.
Abstract:
The medical records of 64 patients between 1 and 11 years old with known onset of an amblyopia-inducing condition were retrospectively reviewed to determine the upper age limit for the development of amblyopia. Thirty seven patients (group 1) developed amblyopia and 27 patients (group 2) did not. The mean patient age at the onset of the amblyopia-inducing condition was 41.0 months (2.90 SE) for group 1 and 92.3 months (4.02 SE) for group 2. The difference was statistically significant (P = .0001). No patient developed amblyopia after 73 months of age. The duration of the amblyopia-inducing condition and the type of amblyopia-inducing condition were not significantly different between the two groups. The age of the patient when exposed to an amblyopia-inducing condition is the most important determinant for the development of amblyopia. Patients 6 years or older with a normal visual system have a low probability of developing amblyopia following the onset of an amblyopia-inducing condition.